BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sans M, Salas A, Soriano A, Prats N, Gironella M, Pizcueta P, Elena M, Anderson DC, Piqué JM, Panés J. Differential role of selectins in experimental colitis. Gastroenterology. 2001;120:1162-1172. [PMID: 11266380 DOI: 10.1053/gast.2001.23252] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Beck PL, Ihara E, Hirota SA, MacDonald JA, Meng D, Nanthakumar NN, Podolsky DK, Xavier RJ. Exploring the interplay of barrier function and leukocyte recruitment in intestinal inflammation by targeting fucosyltransferase VII and trefoil factor 3. Am J Physiol Gastrointest Liver Physiol 2010;299:G43-53. [PMID: 20299601 DOI: 10.1152/ajpgi.00228.2009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
2 Dold S, Laschke MW, Zhau Y, Schilling M, Menger MD, Jeppsson B, Thorlacius H. P-selectin glycoprotein ligand-1-mediated leukocyte recruitment regulates hepatocellular damage in acute obstructive cholestasis in mice. Inflamm Res 2010;59:291-8. [PMID: 19826766 DOI: 10.1007/s00011-009-0099-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Panés J, Salas A. Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. J Crohns Colitis 2018;12:S633-40. [PMID: 30137311 DOI: 10.1093/ecco-jcc/jjy011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
4 Peralta C, Perales JC, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C, Prats N, Fernández L, Gelpí E, Panés J. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am J Pathol. 2002;160:2111-2122. [PMID: 12057915 DOI: 10.1016/s0002-9440(10)61160-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
5 José León A, Garrote JA, Arranz E. [Cytokines in the pathogenesis of inflammatory bowel diseases]. Med Clin (Barc). 2006;127:145-152. [PMID: 16831396 DOI: 10.1157/13090382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
6 Fiorucci S, Wallace JL, Mencarelli A, Distrutti E, Rizzo G, Farneti S, Morelli A, Tseng JL, Suramanyam B, Guilford WJ. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci USA. 2004;101:15736-15741. [PMID: 15505205 DOI: 10.1073/pnas.0404722101] [Cited by in Crossref: 118] [Cited by in F6Publishing: 109] [Article Influence: 6.9] [Reference Citation Analysis]
7 March S, Garcia-pagan J, Massaguer A, Pizcueta P, Panes J, Engel P, Bosch J. P-selectin mediates leukocyte rolling in concanavalin-A-induced hepatitis. Liver Int 2005;25:1053-60. [DOI: 10.1111/j.1478-3231.2005.01137.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
8 Panés J, Aceituno M, Gil F, Miquel R, Piqué JM, Salas A, McLean P. Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007;293:G739-48. [PMID: 17656448 DOI: 10.1152/ajpgi.00059.2007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
9 Ajuebor MN, Kunkel SL, Hogaboam CM. The role of CCL3/macrophage inflammatory protein-1α in experimental colitis. European Journal of Pharmacology 2004;497:343-9. [DOI: 10.1016/j.ejphar.2004.07.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
10 Salaga M, Binienda A, Draczkowski P, Kosson P, Kordek R, Jozwiak K, Fichna J. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis. Peptides 2018;108:34-45. [PMID: 30179653 DOI: 10.1016/j.peptides.2018.08.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
11 Seguí J, Gironella M, Sans M, Granell S, Gil F, Gimeno M, Coronel P, Piqué JM, Panés J. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J Leukoc Biol. 2004;76:537-544. [PMID: 15197232 DOI: 10.1189/jlb.0304196] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 6.2] [Reference Citation Analysis]
12 Schreiber O, Petersson J, Phillipson M, Perry M, Roos S, Holm L. Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009;296:G534-42. [DOI: 10.1152/ajpgi.90470.2008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
13 Angulo S, Llopis M, Antolín M, Gironella M, Sans M, Malagelada JR, Piqué JM, Guarner F, Panés J. Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006;291:G1155-G1162. [PMID: 16901988 DOI: 10.1152/ajpgi.00446.2005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
14 Impellizzeri D, Cuzzocrea S. Targeting selectins for the treatment of inflammatory diseases. Expert Opinion on Therapeutic Targets 2013;18:55-67. [DOI: 10.1517/14728222.2013.841140] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
15 Panés J. Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions. Acta Physiol Scand. 2001;173:159-165. [PMID: 11678739 DOI: 10.1046/j.1365-201X.2001.00905.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Elizalde JI, Mendez A, Gomez J, del Rivero M, Gironella M, Closa D, Quintero E, Pique JM. Gastric Mucosal Blood Flow Changes in Helicobacter pylori Infection and NSAID-Induced Gastric Injury. Helicobacter 2003;8:124-31. [DOI: 10.1046/j.1523-5378.2003.00133.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
17 Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol. 2002;16:933-943. [PMID: 12473299 DOI: 10.1053/bega.2002.0354] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 5.2] [Reference Citation Analysis]
18 Koboziev I, Karlsson F, Grisham MB. Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation. Ann N Y Acad Sci. 2010;1207 Suppl 1:E86-E93. [PMID: 20961311 DOI: 10.1111/j.1749-6632.2010.05711.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.5] [Reference Citation Analysis]
19 Salaga M, Mokrowiecka A, Zielinska M, Malecka-Panas E, Kordek R, Kamysz E, Fichna J. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration. J Pharmacol Exp Ther 2017;363:92-103. [PMID: 28724693 DOI: 10.1124/jpet.117.242586] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
20 Rijcken EM, Laukoetter MG, Anthoni C, Meier S, Mennigen R, Spiegel HU, Bruewer M, Senninger N, Vestweber D, Krieglstein CF. Immunoblockade of PSGL-1 attenuates established experimental murine colitis by reduction of leukocyte rolling. Am J Physiol Gastrointest Liver Physiol 2004;287:G115-24. [PMID: 15001428 DOI: 10.1152/ajpgi.00207.2003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
21 Arijs I, De Hertogh G, Machiels K, Van Steen K, Lemaire K, Schraenen A, Van Lommel L, Quintens R, Van Assche G, Vermeire S. Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. Am J Gastroenterol. 2011;106:748-761. [PMID: 21326222 DOI: 10.1038/ajg.2011.27] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 10.0] [Reference Citation Analysis]
22 Magro F, Araujo F, Pereira P, Meireles E, Diniz-Ribeiro M, Velosom FT. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:1265-1274. [PMID: 15387356 DOI: 10.1023/b:ddas.0000037822.55717.31] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
23 Ley K, Reutershan J. Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol 2006;:97-133. [PMID: 16999226 DOI: 10.1007/3-540-36028-x_4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
24 Rivera-Nieves J, Gorfu G, Ley K. Leukocyte adhesion molecules in animal models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1715-1735. [PMID: 18523998 DOI: 10.1002/ibd.20501] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
25 Magro F, Araujo F, Pereira P, Meireles E, Diniz-Ribeiro M, Velosom FT. Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:1265-1274. [PMID: 15387356 DOI: 10.1023/b: ddas.0000037822.55717.31] [Reference Citation Analysis]
26 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
27 Angiari S. Selectin-mediated leukocyte trafficking during the development of autoimmune disease. Autoimmunity Reviews 2015;14:984-95. [DOI: 10.1016/j.autrev.2015.06.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
28 Koenecke C, Förster R. CCR9 and inflammatory bowel disease. Expert Opinion on Therapeutic Targets 2009;13:297-306. [DOI: 10.1517/14728220902762928] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
29 Wan MX, Riaz AA, Schramm R, Wang Y, Vestweber D, Menger MD, Thorlacius H. Leukocyte rolling is exclusively mediated by P-selectinin colonic venules. Br J Pharmacol 2002;135:1749-56. [PMID: 11934816 DOI: 10.1038/sj.bjp.0704638] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
30 Okanishi H, Kagawa Y, Watari T. Expression of selectins and P-selectin glycoprotein ligand-1 in dogs with lymphocytic–plasmacytic enteritis. Veterinary Immunology and Immunopathology 2014;161:42-8. [DOI: 10.1016/j.vetimm.2014.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Sałaga M, Mokrowiecka A, Jacenik D, Cygankiewicz AI, Małecka-panas E, Kordek R, Krajewska WM, Sobocinska MK, Kamysz E, Fichna J. Systemic Administration of Sialorphin Attenuates Experimental Colitis in Mice via Interaction With Mu and Kappa Opioid Receptors. Journal of Crohn's and Colitis 2017;11:988-98. [DOI: 10.1093/ecco-jcc/jjx043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]